Numira Biosciences, Inc. Names New Board Member
SALT LAKE CITY, Aug. 11, 2011 /PRNewswire/ -- Numira Biosciences, a specialty contract research organization and leader in high resolution, 3D imaging services and visualization software for the life science market, today announced that it has appointed William M. Harrison to its Board of Directors.
Mr. Harrison currently serves as the Chief Executive Officer at VIDA Sciences, a CRO consulting firm based in Kalamazoo, Michigan. Prior to founding VIDA Sciences, Mr. Harrison held a number of senior management positions at MPI Research, a large international CRO based in Mattawan, Michigan. Most notably, during his last ten years at MPI, he held the position of President and Chief Operating Officer. Additionally, Mr. Harrison is an active member of the Society of Quality Assurance and serves on the Board of Trustees for the Kalamazoo Valley Community College Foundation and the Borgess Medical Center, as well as serving as a board member for the American Life Sciences Innovation Council.
"We are pleased that Bill has joined our board," said Michael Beeuwsaert, President and CEO of Numira. "His 25 years of senior management and regulatory compliance experience in a high-growth, preclinical services environment will be of great value to Numira as we move to the next level as a company."
About Numira Biosciences
Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries. Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other areas of disease and/or therapy. Moreover, we are a recognized leader in high-resolution, quantitative imaging for drug and device development. Numira, a privately-held company, is venture-backed by vSpring Captital, the Tech Coast Angels, and Crocker Ventures. For more information on Numira, please visit www.numirabio.com.
SOURCE Numira Biosciences